Amyloid Oligomers (A11) Antibody (OASE00468)

Aviva Systems Biology

Amyloid Oligomers (A11) Antibody (OASE00468)

23

ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry

Research Use Only

Polyclonal

HRP

Liquid. PBS, 50% glycerol, 0.09% sodium azide

EIF3G

eukaryotic translation initiation factor 3 subunit G

eIF3-delta; EIF3-P42; eIF3-p44; EIF3S4; eukaryotic translation initiation factor 3 RNA-binding subunit; eukaryotic translation initiation factor 3 subunit G; eukaryotic translation initiation factor 3 subunit p42; eukaryotic translation initiation factor 3, subunit 4 delta, 44kDa

Rabbit

Amyloid monomeric proteins can sometimes oligomerize into destructive amyloid fibrils. Amyloidogenic conformations of non-disease related proteins can be created by partial protein misfolding or denaturation. Many degenerative diseases are known to be related to the accumulation of misfolded proteins as amyloid fibres (1, 2). These include the amyloid-beta peptide plaques and tau neurofibrillary tangles in senile plaques of Alzheimers symptomology, the deposition of I+/--synuclein in the Lewy bodies of Parkinsons disease, and accumulation of polyglutamine-containing aggregates in Huntingtons disease (2, 3).

Human, Mouse, Rat, Other Species

-20°C

12352203